Milestone Scientific Inc. (MLSS)
NYSEAMERICAN: MLSS · Real-Time Price · USD
0.809
-0.001 (-0.14%)
Nov 4, 2024, 4:00 PM EST - Market closed

Company Description

Milestone Scientific Inc., a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally.

The company operates through Dental and Medical segments. Its products include CompuDent and STA Single Tooth Anesthesia System that are used for all dental procedures that require local anesthetic.

In addition, the company offers CompuFlo, a computer-controlled drug delivery system for the painless delivery of drugs, anesthetics, and other medicaments, as well as for the aspiration of bodily fluids or previously injected substances, and disposable injection handpiece for the tactile control during the injection.

Further, it provides CompuFlo Epidural, a computer-controlled anesthesia system for use in various medical applications.

Additionally, the company offers company offers CompuMed for use in various medical procedures performed in plastic, hair restoration, and colorectal surgery, as well as podiatry, dermatology, orthopedics, and various other disciplines.

Milestone Scientific Inc. was incorporated in 1989 and is headquartered in Roseland, New Jersey.

Milestone Scientific Inc.
Milestone Scientific logo
Country United States
Founded 1989
IPO Date Nov 3, 1995
Industry Medical Instruments & Supplies
Sector Healthcare
Employees 17
CEO Jan Haverhals

Contact Details

Address:
425 Eagle Rock Avenue, Suite 403
Roseland, New Jersey 07068
United States
Phone 973 535 2717
Website milestonescientific.com

Stock Details

Ticker Symbol MLSS
Exchange NYSEAMERICAN
Fiscal Year January - December
Reporting Currency USD
CIK Code 0000855683
CUSIP Number 59935P209
ISIN Number US59935P2092
Employer ID 13-3545623
SIC Code 3842

Key Executives

Name Position
Jan Adriaan Haverhals President, Chief Executive Officer and Director
Leonard A. Osser Founder and Vice Chairman
James Hippett J.D. Senior Vice President and Global Sales and Business Development
Keisha Harcum Controller

Latest SEC Filings

Date Type Title
Sep 27, 2024 8-K Current Report
Sep 11, 2024 144 Filing
Aug 14, 2024 10-Q Quarterly Report
Jul 18, 2024 8-K Current Report
Jun 5, 2024 DEF 14A Other definitive proxy statements
May 15, 2024 10-Q Quarterly Report
Apr 9, 2024 8-K Current Report
Mar 29, 2024 10-K Annual Report
Jan 12, 2024 8-K Current Report
Dec 12, 2023 8-K Current Report